Mega Lifesciences Public Company Limited Reports Consolidated Earnings Results for the Second Quarter and Half Year of 2020
August 14, 2020 at 06:28 am EDT
Share
Mega Lifesciences Public Company Limited reported consolidated earnings results for the second quarter and half year of 2020. For the quarter, the company reported total income of THB 2,643.6 million against THB 2,655.4 million a year ago. Operating revenue was THB 2,633.3 million against THB 2,643.5 million a year ago. Reported net profit was THB 303.4 million or THB 0.35 per basic share against THB 220.4 million or THB 0.25 per basic share a year ago.
For the six months, the company reported total income of THB 5,729.0 million against THB 5,252.0 million a year ago. Operating revenue was THB 5,710.4 million against THB 5,229.5 million a year ago. Reported net profit was THB 623.3 million or THB 0.71 per basic share against THB 474.1 million or THB 0.55 per basic share a year ago.
Mega Lifesciences Public Company Limited is engaged in manufacturing, marketing, selling and distributing quality pharmaceutical, nutraceutical products and Fast-Moving Consumer Goods (FMCG). Its segments include Maxxcare distribution business, Mega We Care branded products business, and original equipment manufacturer (OEM) business. The Maxxcare distribution business markets, sells and distributes various branded prescription pharmaceutical products, OTC and FMCG products. Its services include warehouse management, collections, including assuming the liability for bad debts, and value-added services. Its Mega We Care branded products business develops, manufactures, markets and sells its own brand of nutraceutical products, prescription pharmaceutical products and OTC products. Mega We Care branded products are sold in a total of 35 countries around the world. Its manufacturing facilities in Thailand and Australia accept various production orders from third-party customers.
MEGA LIFESCIENCES 
